文献速递免疫规划妇幼与学校卫生卫生政策与健康促进

针对新西兰奥特亚罗瓦的澳大利亚疫苗障碍评估工具(VBAT)本地化调适:采用本地公平方法

Tailoring the Australian vaccine barriers assessment tool (VBAT) for Aotearoa New Zealand: Using a local equity approach.
PubMed 文献 · Vaccine · 2026-04-30

本研究将澳大利亚疫苗障碍评估工具(VBAT)调适为适用于新西兰奥特亚罗瓦(ANZ)的版本,以改善儿童免疫接种覆盖率,尤其针对毛利和太平洋岛民儿童。通过文献回顾、认知测试、信效度调查及与疫苗接种记录关联的预测效度评估,最终形成6条目短版和14条目长版问卷,两者在解释接种差异上均优于美国PACV调查。

要点

  • NZ VBAT通过三阶段开发验证,最终短版6条目涵盖安全、可及性、有效性、意图和影响五个域。
  • 长版14条目增加社会责任和与提供者关系两个域。
  • 短版和长版分别解释13%和14%的接种差异,优于PACV的10%。

核心结论

  • NZ VBAT是文化适宜的工具,可识别新西兰5岁以下儿童疫苗接种不足的社会和行为驱动因素。
  • 该工具将支持制定有针对性的干预措施,以实现最佳免疫覆盖并减少公平差距。

研究设计与样本

  • NZ VBAT分三阶段开发验证:文献回顾与认知理论及认知测试;调查评估条目信度并通过专家共识选择条目;调查评估未来免疫接种的预测效度,并与疫苗接种记录关联。
  • 采用验证性复合分析(CCA)评估最终优选模型的拟合度。

主要发现

  • 阶段1识别80个条目,经认知测试精炼至45个。
  • 阶段2中467份调查评估了条目信度。
  • 阶段3中492名照护者/父母中的314名(64%)完成了最终35条目调查,其中82%为毛利和太平洋岛民;176份回答与免疫记录关联。
  • 逻辑回归显示可及性和接受性障碍与疫苗接种 uptake 强相关。
  • 最终6条目短版调查包含五个域:安全、可及性、有效性、意图和影响;14条目长版调查增加社会责任和与提供者关系两个域。

关键数值与推荐

  • 最终短版调查为6条目,涵盖五个域;长版调查为14条目,涵盖七个域。
  • 短版和长版分别解释13%和14%的接种差异,PACV解释10%。

临床怎么用

  • NZ VBAT可用于识别新西兰5岁以下儿童疫苗接种不足的社会和行为驱动因素。
  • 该工具支持制定有针对性的干预措施,以改善免疫覆盖并减少公平差距。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is need for international tools to measure and monitor childhood immunisation programme uptake, validated specifically for local country context. Childhood vaccine coverage has declined in Aotearoa New Zealand (ANZ) since 2016, especially for Māori and Pacific Peoples. OBJECTIVES: To adapt the Australian Vaccine Barriers Assessment Tool (VBAT) for ANZ context, to support improvement of vaccination coverage, particularly for Māori and Pacific Peoples children. METHODS: The NZ VBAT was developed and validated in three stages: (1) Literature review and cognitive theory, refined through cognitive testing in ANZ. (2) Surveys assessing reliability of potential items and selection of items via expert consensus. (3) Surveys assessing predictive validity of future immunisation, with responses linked to vaccination records. Confirmatory Composite Analysis (CCA) assessed fit of the final preferred models. RESULTS: Stage 1 identified 80 items, refined to 45 through cognitive testing. In stage 2, 467 surveys assessed item reliability. In stage 3, 314 out of 492 (64%) carers/parents (82% Māori and Pacific Peoples) completed the final 35 item survey, with 176 responses linked to immunisation records. Logistic regression showed strong associations between access and acceptance barriers and vaccine uptake. The final 6-item short survey had five domains encompassing safety, access, effectiveness, intention and influence; whilst the 14 -item long survey incorporated two additional domains: social responsibility and relationship with provider. Both surveys outperformed the US Parent Attitudes Childhood Vaccines (PACV) Survey, explaining 13% and 14% of uptake variation compared to PACV's 10%. CONCLUSION: The NZ Vaccine Barriers Assessment tools (NZ VBAT) is a culturally appropriate tool to identify the social and behavioural drivers of suboptimal vaccination in children <5 years in NZ. It will support development of targeted interventions to achieve optimal immunisation coverage and reduce equity gaps.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Turner N, Castelino L, Paynter J, et al. Tailoring the Australian vaccine barriers assessment tool (VBAT) for Aotearoa New Zealand: Using a local equity approach. Vaccine. 2026. PMID: 42066580. doi:10.1016/j.vaccine.2026.128636

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。